Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review

Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review

Jad El Tom1, Alisar Serhan2, Tarek Safi3, Wissam K Kabbara4

1School of Pharmacy, Lebanese American University (LAU), Byblos, Lebanon; 2Hospital Pharmacist, Saint George Hospital University Medical Center, Beirut, Lebanon;3Saarland University Medical Center, Homburg, Germany; 4Clinical Associate Professor, Department of Pharmacy Practice, School of Pharmacy, Lebanese American University (LAU), Byblos, Lebanon.

Introduction: The role of the clinical pharmacist in the management of acute pancreatitis has not been researched extensively, and only a few published studies on the topic can be found. This clinical review presents all pertinent published data and serves as a guide for clinical pharmacists who participate in the management of patients with acute pancreatitis.

Methods: An extensive literature search was conducted on PubMed from 1990 to 2021 to retrieve relevant studies focusing on the role of the clinical pharmacist in the treatment of acute pancreatitis.

Results: An analysis of the medications that are associated with acute pancreatitis is presented, highlighting the responsibility of the pharmacist to conduct a thorough medication investigation in order to identify a possible drug-induced acute pancreatitis. Medical management of acute pancreatitis, mainly fluid therapy, is an area where a clinical pharmacist can appropriately intervene. Proper choice of fluid therapy and its rate, nutritional considerations, pain management and antibiotic use, are all important to consider for a successful treatment with minimal adverse effects. It is well documented in the literature that clinical pharmacists can decrease hospital costs. Discharge counseling performed by a clinical pharmacist has been shown to increase patient compliance and decrease both readmission rates and follow-up physician visits.

Conclusion: The clinical pharmacist, as the primary drug expert, can identify medication-induced pancreatitis, diminish the use of unnecessary antibiotics, improve patient care and decrease the overall costs.

Keywords: acute pancreatitis, adverse drug reaction, clinical pharmacist, pharmacist intervention, pharmaceutical care.

Free Full-text PDF

How to cite this article:
Jad El Tom, Alisar Serhan, Tarek Safi, Wissam K Kabbara. Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review. International Journal of Hospital Pharmacy, 2021, 6:41. DOI: 10.28933/ijhp-2021-06-0605


1. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-11.
2. Roberts SE, Morrison-Rees S, John A, Williams JG, Brown TH, Samuel DG. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017;17(2):155-65.
3. Banks PA, Freeman ML, Practice Parameters Committee of the American College of G. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379-400.
4. Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ. 2019;367:l6227.
5. Gravante G, Garcea G, Ong SL, Metcalfe MS, Berry DP, Lloyd DM, et al. Prediction of mortality in acute pancreatitis: a systematic review of the published evidence. Pancreatology. 2009;9(5):601-14.
6. Wang GJ, Gao CF, Wei D, Wang C, Ding SQ. Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol. 2009;15(12):1427-30.
7. Kaufmann CP, Stampfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376.
8. Yang P, Jiang S-P, Lu X-Y. Effectiveness of continuous improvement by a clinical pharmacist-led guidance team on the prophylactic antibiotics usage rationality in intervention procedure at a Chinese tertiary teaching hospital. Ther Clin Risk Manag. 2017;13:469-76.
9. Malfara M, Pernassi M, Aragon D, Carlotti A. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit. Int J Clin Pharm. 2018;40(3):513-9.
10. Yang H, Li L, Hu X, Wang W, Yang X, Liu H, et al. Impact of pharmacist-led post-transplant medication management for kidney transplant recipients: A retrospective pre- and post-intervention study. J Clin Pharm Ther. 2019;44(4):603-10.
11. Niu JL, Ding YL, Ju F, Lu T, Xue T, Chen KX, et al. Effect of clinical pharmacist intervention on the treatment of acute pancreatitis. Int J Clin Pharm. 2019;41(6):1652-7.
12. Tenner S, Baillie J, DeWitt J, Vege SS, American College of G. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-15; 16.
smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6(2):e009828.
13. Lowenfels AB, Maisonneuve P, Sullivan T. The changing character of acute pancreatitis: epidemiology, etiology, and prognosis. Curr Gastroenterol Rep. 2009;11(2):97-103.
14. Gullo L, Migliori M, Olah A, Farkas G, Levy P, Arvanitakis C, et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas. 2002;24(3):223-7.
15. Setiawan VW, Monroe K, Lugea A, Yadav D, Pandol S. Uniting Epidemiology and Experimental Disease Models for Alcohol-Related Pancreatic Disease. Alcohol Res. 2017;38(2):173-82.
16. Setiawan VW, Pandol SJ, Porcel J, Wilkens LR, Le Marchand L, Pike MC, et al. Prospective Study of Alcohol Drinking, Smoking, and Pancreatitis: The Multiethnic Cohort. Pancreas. 2016;45(6):819-25.
17. Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169(11):1035-45.
18. Brown TJ, Todd A, O’Malley C, Moore HJ, Husband AK, Bambra C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction,
19. Shafqet M, Sharzehi K. Diabetes and the Pancreatobiliary Diseases. Curr Treat Options Gastroenterol. 2017;15(4):508-19.
20. Gonzalez-Perez A, Schlienger RG, Rodriguez LA. Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study. Diabetes Care. 2010;33(12):2580-5.
21. Tenner S. Drug induced acute pancreatitis: does it exist? World J Gastroenterol. 2014;20(44):16529-34.
22. Jones MR, Hall OM, Kaye AM, Kaye AD. Drug-induced acute pancreatitis: a review. Ochsner J. 2015 Spring;15(1):45–51.
23. Spanier BW, Tuynman HA, van der Hulst RW, Dijkgraaf MG, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol. 2011;106(12):2183-8.
24. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648-61
25. Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013;173(7):534-9.
26. BOXED WARNING. FULL PRESCRIBING INFORMATION [Internet]. [cited 2020 Nov 22]. Available from:
27. Bryant AE, 3rd, Dreifuss FE. Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology. 1996;46(2):465-9.
28. Thisted H, Jacobsen J, Munk EM, Norgaard B, Friis S, McLaughlin JK, et al. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther. 2006;23(1):185-90.
29. Anagnostopoulos GK, Tsiakos S, Margantinis G, Kostopoulos P, Arvanitidis D. Acute pancreatitis due to pravastatin therapy. Jop. 2003;4(3):129-32.
30. Maringhini A, Termini A, Patti R, Ciambra M, Biffarella P, Pagliaro L. Enalapril-associated acute pancreatitis: recurrence after rechallenge. Am J Gastroenterol. 1997;92(1):166-7.
31. Carnovale A, Esposito P, Bassano P, Russo L, Uomo G. Enalapril-induced acute recurrent pancreatitis. Dig Liver Dis. 2003;35(1):55-7.
32. Madsen JS, Jacobsen IA. Angiotensin converting enzyme inhibitor therapy and acute pancreatitis. Blood Press. 1995;4(6):369-71.
33. Gonzalez Ramallo VJ, Muino Miguez A, Torres Segovia FJ. Necrotizing pancreatitis and enalapril. Eur J Med. 1992;1(2):123.
34. Birck R, Keim V, Fiedler F, van der Woude FJ, Rohmeiss P. Pancreatitis after losartan. Lancet. 1998;351(9110):1178.
35. Clunie GPR, Lennard L. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. Rheumatology (Oxford). 2004;43(1):13–8.
36. Nogueira JR, Freedman MA. Acute pancreatitis as a complication of Imuran therapy in regional enteritis. Gastroenterology. 1972;62(5):1040-1.
37. Teich N, Mohl W, Bokemeyer B, Bundgens B, Buning J, Miehlke S, et al. Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases–A Prospective Study on Incidence and Severity. J Crohns Colitis. 2016;10(1):61-8.
38. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007;298(11):1312-22.
39. Bosch X, Bernadich O. Acute pancreatitis during treatment with amiodarone. Lancet. 1997;350(9087):1300.
40. Sastri GV. Gastrointestinal complications of amiodarone therapy. J Clin Gastroenterol. 1990;12:70-7.
41. Famularo G, Minisola G, Nicotra GC, De Simone C. Acute pancreatitis caused by amiodarone. Eur J Emerg Med. 2004;11(5):305-6.
42. Forsmark Ch E, Vege SS, Wilcox CM. Acute Pancreatitis. N Engl J Med. 2017;376(6):598-9.
43. Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN, Amer. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis. Gastroenterology. 2018;154(4):1096-101.
44. Wu BU, Hwang JQ, Gardner TH, Repas K, Delee R, Yu S, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9(8):710-7 e1.
45. Choosakul S, Harinwan K, Chirapongsathorn S, Opuchar K, Sanpajit T, Piyanirun W et al. Comparison of normal saline versus Lactated Ringer’s solution for fluid resuscitation in patients with mild acute pancreatitis, A randomized controlled trial. Pancreatology. 2018;18(5):507-512.
46. Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4(1):177-97.
47. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330(17):1198-210.
48. Eckerwall GE, Tingstedt BB, Bergenzaun PE, Andersson RG. Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery–a randomized clinical study. Clin Nutr. 2007;26(6):758-63.
49. Jacobson BC, Vander Vliet MB, Hughes MD, Maurer R, McManus K, Banks PA. A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin Gastroenterol Hepatol. 2007;5(8):946-51
50. Gupta R, Patel K, Calder PC, Yaqoob P, Primrose JN, Johnson CD. A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II > or =6). Pancreatology. 2003;3(5):406-13.
51. Gianotti L, Meier R, Lobo DN, Bassi C, Dejong CH, Ockenga J, et al. ESPEN Guidelines on Parenteral Nutrition: pancreas. Clin Nutr. 2009;28(4):428-35.
52. Tucker A, Ybarra J, Bingham A, Blackmer A, Curtis C, Mattox T, et al. American society for parenteral and enteral nutrition (A.S.P.E.N.) standards of practice for nutrition support pharmacists. Nutr Clin Pract. 2015;30(1):139-46.
53. Schorn SC, Güralp O. Tieftrunk, Elke. Friess, Helmut. Demir, Ihsan Ekin. Pain Management in Acute Pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base. 2015.
54. Gardner TB, Vege SS, Pearson RK, Chari ST. Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol. 2008;6(10):1070-6.
55. Petrov MS, McIlroy K, Grayson L, Phillips AR, Windsor JA. Early nasogastric tube feeding versus nil per os in mild to moderate acute pancreatitis: a randomized controlled trial. Clin Nutr. 2013;32(5):697-703.
56. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56(6):514-7, e202-5.
57. Helm JF, Venu RP, Geenen JE, Hogan WJ, Dodds WJ, Toouli J, et al. Effects of morphine on the human sphincter of Oddi. Gut. 1988;29(10):1402-7.
58. R. Jakobs, M. U. Adamek, A. C. Von. Buprenorphine or Procaine for Pain Relief in Acute Pancreatitis. A Prospective Randomized Study. Scandinavian Journal of Gastroenterology. 2000;35(12):1319-1323.
59. Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001;96(4):1266-72.
60. Peiro AM, Martinez J, Martinez E, de Madaria E, Llorens P, Horga JF, et al. Efficacy and tolerance of metamizole versus morphine for acute pancreatitis pain. Pancreatology. 2008;8(1):25-9.
61. Basurto Ona X, Rigau Comas D, Urrutia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013(7):CD009179.
62. de Vries AC, Besselink MG, Buskens E, Ridwan BU, Schipper M, van Erpecum KJ, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology. 2007;7(5-6):531-8.
63. Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg. 2006;93(6):674-84.
64. File TM, Jr., Srinivasan A, Bartlett JG. Antimicrobial stewardship: importance for patient and public health. Clin Infect Dis. 2014;59 Suppl 3:S93-6.
65. Rana SS. An overview of walled-off pancreatic necrosis for clinicians. Expert Rev Gastroenterol Hepatol. 2019;13(4):331-43.
66. Isenmann R, Friess H, Schlegel P, Fleischer K, Büchler MW. Penetration of ciprofloxacin into the human pancreas. Infection. 1994;22(5):343-6.
67. Seewald S, Groth S, Omar S, Imazu H, Seitz U, de Weerth A, et al. Aggressive endoscopic therapy for pancreatic necrosis and pancreatic abscess: a new safe and effective treatment algorithm (videos). Gastrointest Endosc. 2005;62(1):92-100.
68. Rao C, Bhasin DK, Rana SS, Gupta R, Gautam V, Singh K. Implications of culture positivity in acute pancreatitis: does the source matter? J Gastroenterol Hepatol. 2013;28(5):887-92.
69. Otto W, Komorzycki K, Krawczyk M. Efficacy of antibiotic penetration into pancreatic necrosis. HPB: the official journal of the International Hepato Pancreato Biliary Association. 2006;8(1):43-8.
70. Leppaniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27.
71. De Waele JJ. Rational use of antimicrobials in patients with severe acute pancreatitis. Semin Respir Crit Care Med. 2011;32(2):174-80.
72. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health Syst Pharm. 1997;54(4):431-4.
73. Lowe M S. Nutritional advice for prevention of acute pancreatitis: review of current opinion. Nutrition and Dietary Supplements. 2012;4:70-1.
74. Jordan MA, Harmon J. Pharmacist interventions for obesity: improving treatment adherence and patient outcomes. Integr Pharm Res Pract. 2015;4:79-89.
75. Black JH, 3rd. Evidence base and strategies for successful smoking cessation. J Vasc Surg. 2010;51(6):1529-37.
76. Ahmed Ali U, Issa Y, Hagenaars JC, Bakker OJ, van Goor H, Nieuwenhuijs VB, et al. Risk of Recurrent Pancreatitis and Progression to Chronic Pancreatitis After a First Episode of Acute Pancreatitis. Clin Gastroenterol Hepatol. 2016;14(5):738-46.
77. Pfortmueller CA, Funk GC, Reiterer C, Schrott A, Zotti O, Kabon B, et al. Normal saline versus a balanced crystalloid for goal-directed perioperative fluid therapy in major abdominal surgery: a double-blind randomised controlled study. Br J Anaesth. 2018;120(2):274-83.
78. Yi F, Ge L, Zhao J, Lei Y, Zhou F, Chen Z, et al. Meta-analysis: total parenteral nutrition versus total enteral nutrition in predicted severe acute pancreatitis. Intern Med. 2012;51(6):523-30.
79. Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):825-73.
80. Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S, et al. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019;156(1):218-26.
81. Buchler M, Malfertheiner P, Friess H, Isenmann R, Vanek E, Grimm H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992;103(6):1902-8.